Marta Sánchez‐Soto

This paper designs cell-specific small molecule cytotoxics using AI, combining screening, machine learning, and reinforcement learning, resulting in validated compounds with improved hit discovery rates.

The paper identifies molecular signatures of Alzheimer's disease in AD mouse models and finds drugs that reverse these signatures and cognitive impairment.

The paper develops new DREADD agonists and a PET radiotracer for improved neuronal activity manipulation and noninvasive projection mapping in neurotheranostics.